FDA Panel Backs Powerful Opioid Pills for Emergency Pain
·
SILVER SPRING, Md. -- An FDA advisory committee voted 10-3 on Friday in favor of recommending approval of sufentanil sublingual tablets for the treatment of moderate-to-severe acute pain.
After the FDA rejected an initial new drug application this time last year, the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) said the adjustments made by drugmaker AcelRx were sufficient to support the safety and efficacy of the new opioid analgesic.
|
|
SAVE THE DATES!
February 22-24, 2019
Orlando, FL
|
|
Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
A 7-item pain intensity measure for persons with dementia (PIMD) has shown initial validity and reliability, according to a study published in Pain Medicine.
The PIMD was developed using items from existing pain observational measures. Further testing will evaluate its sensitivity to changes in pain intensity. The PIMD evaluates 7 behaviors, and the intensity of those behaviors is rated on a scale of 0 (absent) to 3 (severe). The behaviors assessed are bracing, rigid or stiff body part, sighing, complaining, grimacing, frowning, and expressive eyes.
|
|
Interventional Pain Management Reports
is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine.
Interventional Pain Management Reports
is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of
Pain Physician
.
Interventional Pain Management Reports Interventional Pain Management Reports
is an open access journal, available online with free full manuscripts.
The benefits of publishing in an open access journal that has a corresponding
print edition journal are:
- Your article will have the potential to obtain more citations.
- Your article will be peer-reviewed and published faster than other journals.
- Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.
- Open Access journals are FREE to view, download and to print.
So submit today your:
- Case Reports
- Technical Reports
- Editorials
- Short Perspectives
|
|
Chronic Pain May Be a Contributing Factor to Suicide
Chronic pain may represent an important contributing factor to
suicide
, according to a study published in the
Annals of Internal Medicine
.
To determine the prevalence of chronic pain among those who die by suicide, researchers conducted a retrospective analysis of data compiled by the National Violent Death Reporting System. A total of 123,181 suicide decedents age ≥10 years from 18 states who died between January 2003 and December 2014 were included in the study. For each individual, several aspects relevant to their death were reviewed, including demographic characteristics, toxicology results, precipitating circumstances, and suicide planning and intent.
|
|
October PodCast Now Available
ASIPP President Hans Hansen, MD, is back with another of his excellent podcasts.
At the October meeting Dr. Hansen interviewed Ricardo Vallejo, MD, of Bloomington, IL. Vallejo served on the faculty of ASIPP's Interventional Techniques Comprehensive Review Course and Cadaver Workshop held earlier this month in Memphis.
Dr. Vallejo, Co-Founder, Director of Research at Millennium Pain Center in Bloomington, Illinois, has been partners with Ramsin Benyamin for over 15 years. He received his medical degree in Colombia and then pursued his PhD in Immunology at the Complutense University in Madrid, Spain. During his residency in Anesthesiology at the University of Miami he became Chief Residence of the program and served as resident representative for the Florida Society of Anesthesiology and The American Society of Anesthesiology. Dr. Vallejo then pursued his fellowship in Pain Medicine at Harvard Medical School at Massachusetts General Hospital. He is considered a world leader in Stimulation and shares his ideas during this podcast.
Dr. Hansen explains that ASIPP will be recording ASIPP courses and making them available to the world. So in the near future you'll be able to listen to podcasts on Interventional Techniques from your car, home, boat, etc. Look for that in near future.
|
|
FDA Panel Votes on Drug/Device Combo to Treat Pain in Medically Supervised Setting
The Food and Drug Administration (FDA)'s Anesthetic and Analgesic Drug Products Advisory Committee voted in favor (10-3) of approving Dsuvia (sufentanil sublingual tablet; AcelRx) for the treatment of moderate-to-severe acute pain in adults in a medically supervised setting.
Dsuvia is an investigational, sublingual formulation of sufentanil 30mcg in a disposable, pre-filled, single-dose applicator that is administered by a healthcare professional. Sufentanil is a synthetic opioid analgesic that is 5-10 times more potent than fentanyl. As Dsuvia was “developed to address challenges with existing treatment options”, according to AcelRx, its use could apply in situations where IV access may be limited or in patients with dysphagia who are unable to take an oral drug.
|
|
Pain Physician
September/October 2018 Issue Features
Health Policy Review
- Reframing Medicare Physician Payment Policy for 2019: A Look at Proposed Policy
Systematic Reviews
- Efficacy Assessment of Radiofrequency Ablation as a Palliative Pain Treatment in Patients with Painful Metastatic Spinal Lesions: A Systematic Review
- Comparison of Clinical Efficacy Between Transforaminal and Interlaminar Epidural Injections in Lumbosacral Disc Herniation: A Systematic Review and Meta-Analysis
- Comparison of Clinical Efficacy of Epidural Injection With or Without Steroid in Lumbosacral Disc Herniation: A Systematic Review and Meta-analysis
Randomized Trials
- Effectiveness and Safety of High-Voltage Pulsed Radiofrequency to Treat Patients with Primary Trigeminal Neuralgia: A Multicenter, Randomized, Double-Blind, Controlled Study Protocol
- Preemptive Analgesia with Parecoxib in Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial
- Comparison of Efficacy of Lateral Branch Pulsed Radiofrequency Denervation and Intraarticular Depot Methylprednisolone Injection for Sacroiliac Joint Pain
|
|
Naloxone Rarely Administered by Layperson in Opioid Deaths
HealthDay News — From July 2016 to June 2017, bystanders were documented in 44 percent of
opioid overdose deaths
, but naloxone was rarely administered by a layperson, according to a study published Aug. 31 in
Morbidity and Mortality Weekly Report
.
Christine L. Mattson, Ph.D., from the Centers for Disease Control and Prevention (CDC), and colleagues used data from 11 states participating in the CDC's Enhanced State Opioid Overdose Surveillance program to describe opioid overdose deaths among those testing positive for prescription opioids (e.g., oxycodone and hydrocodone), illicit opioids (e.g., heroin, illicitly manufactured fentanyl, and fentanyl analogs), or both prescription and illicit opioids.
|
|
DOJ News
Dallas Physicians and Nurses Sentenced to Prison for Role in $11 Million Medicare Fraud Scheme
Two Dallas doctors and three nurses were sentenced yesterday in an $11.3 million Medicare fraud scheme involving false and fraudulent claims for home health services.
Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division, U.S. Attorney Erin Nealy Cox of the Northern District of Texas, Special Agent in Charge C.J. Porter of the U.S. Department of Health and Human Services-Office of Inspector General’s (HHS-OIG) Dallas Region, Special Agent in Charge Eric Jackson of the FBI’s Dallas Field Office, and Director of Law Enforcement David Maxwell of the Texas Attorney General’s Medicaid Fraud Control Unit (MFCU), made the announcement
Patience Okoroji, 60, of Dallas County, Texas, was sentenced by U.S. District Judge Reed O’Connor of the Northern District of Texas to serve 120 months in prison for her role in the fraudulent scheme as a part-owner of Timely Home Health Services Inc. (Timely) and a Licensed Vocational Nurse (LVN). Kelly Robinett, M.D., 69, of Denton County, Texas, who was a former part-owner and supervising physician at Boomer House Calls (Boomer) of Frisco, Texas, was sentenced to serve 42 months in prison; Joy Ogwuegbu, 42, of Collin County, Texas, the former Director of Nursing at Timely, was sentenced to serve 42 months in prison and Kingsley Nwanguma, 48, of Dallas County, an LVN at Timely, was sentenced to serve 42 months in prison. Angel Claudio, M.D., 61, of Hidalgo County was sentenced to serve six months in prison.
Health Care CEO Pleads Guilty to $150 Million Health Care Fraud Scheme Involving Harmful Injections and Unnecessary Prescription of Millions of Opioids
A health care CEO pleaded guilty today to a superseding indictment as part of an investigation into a $300 million health care fraud scheme that involved the distribution of over 6.6 million dosage units of controlled substances and the administration of medically unnecessary injections that resulted in patient harm.
Attorney General Jeff Sessions, Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division, U.S. Attorney Matthew Schneider of the Eastern District of Michigan, Special Agent in Charge Timothy R. Slater of the FBI’s Detroit Field Office, Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services Office of Inspector General’s (HHS-OIG) Chicago Region and Special Agent in Charge Manny Muriel of IRS Criminal Investigation (IRS-CI) Detroit made the announcement.
Mashiyat Rashid, 38, of West Bloomfield, Michigan, was the CEO of the Tri-County Wellness Group of medical providers in Michigan and Ohio, and pleaded guilty to one count of conspiracy to commit health care fraud and wire fraud, and one count of money laundering. In connection with his plea agreement, Rashid agreed to the entry of a forfeiture money judgment in the amount of $51,396,917.70, as well as forfeiture to the United States of property traceable to proceeds of the health care fraud scheme, including over $11.5 million, commercial real estate, residential real estate, and a Detroit Pistons season ticket membership.
|
|
November 8-11, 2018
NY/NJSIPP Pain Medicine Symposium 2018
Hyatt Regency Jersey City.
November 12 and 14, 2018
FSIPP Regional Meetings:
November 12, 2
018
@6:30pm
Carrabba's Italian Grill
2370 SW College Road, Ocala, FL 34471
November 14, 2018 @6:30pm
Carrabba's Italian Grill
5820 Red Bug Lake Road, Winter Springs, FL 32708
July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
July 26-28, 2019
PAIN 2019
West Virginia Society of Pain Physicians
Loews Miami Beach, FL
|
|
|
|
|
|
|
